Home / Market News / $RPID

$RPID news and market catalysts

The 4 most recent market catalysts affecting $RPID, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.

4 catalysts 2 high impact 1 bullish 2 bearish Pharmaceuticals/Biotechnology
Nov 16, 2026 Corporate Catalyst Bullish Impact 92
Merck KGaA to Acquire Rapid Micro Biosystems
Merck KGaA has announced its definitive agreement to acquire Rapid Micro Biosystems. This acquisition is a strategic move for Merck, aiming to bolster its Life Science business by …
Sep 29, 2026 Corporate Catalyst Neutral Impact 55
Roth Capital Initiates Coverage On Rapid Micro Biosystems with Buy Rating, Announces Price Target of $3
Roth Capital's initiation of coverage on Rapid Micro Biosystems with a 'Buy' rating and a $3 price target is a positive development for the company. Analyst coverage can increase v…
Aug 7, 2026 Corporate Catalyst Bearish Impact 55
Rapid Micro Biosystems Affirms FY2026 Sales Guidance of $37.000M-$41.000M vs $39.133M Est
Rapid Micro Biosystems (RPID) filed an 8-K to affirm its previously issued sales guidance for fiscal year 2026, setting the range at $37.0 million to $41.0 million. This is a routi…
Aug 7, 2026 Corporate Catalyst Bearish Impact 85
Rapid Micro Biosystems Q2 EPS $(0.27) Misses $(0.24) Estimate, Sales $8.054M Beat $7.875M Estimate
Rapid Micro Biosystems (RPID) announced its Q2 earnings, revealing a mixed performance. The company missed analyst EPS estimates by 12.5%, reporting $(0.27) per share against an ex…
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.